Timothy Sullivan, MD
- ASSISTANT PROFESSOR | Medicine, Infectious Diseases
Dr. Sullivan is an infectious diseases physician who specializes in the treatment and prevention of infections in transplant recipients and other immunocompromised patients. He graduated from the Georgetown University School of Medicine and completed internal medicine and infectious diseases training at Mount Sinai.
American Board of Internal Medicine
MD, Georgetown University Hospital
Residency, Internal Medicine, Mount Sinai School of Medicine
Fellowship, Infectious Disease, Mount Sinai School of Medicine
Khan S, Sullivan T, Ali M, Dunn D, Patel G, Huprikar S. Low-dose valganciclovir for cytomegalovirus prophylaxis in intermediate-risk liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018 Mar;.
Sullivan T. HIV protease inhibitors and mortality following kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2018 Jan;.
Taimur S, Sullivan T, Rana M, Patel G, Roldan J, Ashley K, Pinney S, Anyanwu A, Huprikar S. Successful heart transplantation in patients with total artificial heart infections. Transplant infectious disease : an official journal of the Transplantation Society 2018 Feb; 20(1).
Sullivan T, Taimur S, Rana M, Patel G, Pinney S, Anyanwu A, Huprikar S. Successful heart transplantation in patients with active Staphylococcus bloodstream infection and suspected mechanical circulatory support device infection. Transplant infectious disease : an official journal of the Transplantation Society 2018 Feb; 20(1).
Sullivan T. The Implications of Low Absolute CD4 Counts in Patients With Cirrhosis and Human Immunodeficiency Virus. Open forum infectious diseases 2016 Apr; 3(2).
Sullivan T, Weinberg A, Rana M, Patel G, Huprikar S. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients. Transplantation 2016 Sep; 100(9).
Sullivan T, Ben Amor Y. Global Introduction of New Multidrug-Resistant Tuberculosis Drugs-Balancing Regulation with Urgent Patient Needs. Emerging infectious diseases 2016 Mar; 22(3).
Sullivan T. Declining Interest in Infectious Diseases: An Economic Problem That Requires Economic Solutions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Dec; 63(12).
Bunker DR, Sullivan T. A Case of Leukocytoclastic Vasculitis Caused by Listeria monocytogenes Bacteremia. Case reports in infectious diseases 2016; 2016.
Sullivan T, Brodginski A, Patel G, Huprikar S. The role of secondary cytomegalovirus prophylaxis for kidney and liver transplant recipients. Transplantation 2015 Apr; 99(4).
Sullivan T. Antibiotic overuse and Clostridium difficile: a teachable moment. JAMA internal medicine 2014 Aug; 174(8).
Sullivan T, Reese L, Huprikar S, Lee M. Pulmonary cryptosporidiosis and immune reconstitution inflammatory syndrome: a case report and review. International journal of STD & AIDS 2013 Apr; 24(4).
Sullivan T, Ben Amor Y. What's in a name? The future of drug-resistant tuberculosis classification. The Lancet. Infectious diseases 2013 Apr; 13(4).
Sullivan T, Ben Amor Y. The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS medicine 2012; 9(7).